Cagrilintide/semaglutide
A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
Novo Nordisk · Phase 3 · Withdrawn · Enrollment 0
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| CagriSema B in device 2 + Placebo in device 1 | Obesity or overweight | n/r | 16 | n/r | n/r |
| CagriSema in device 1 + Placebo in device 2 | Obesity or overweight | n/r | 16 | n/r | n/r |
| Placebo in device 1 + Placebo in device 2 | Obesity or overweight | n/r | 16 | n/r | n/r |